Wells Fargo’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$71.3M Buy
911,106
+45,487
+5% +$3.56M 0.01% 654
2025
Q1
$62.7M Buy
865,619
+21,596
+3% +$1.57M 0.01% 660
2024
Q4
$62.5M Buy
844,023
+81,144
+11% +$6.01M 0.01% 661
2024
Q3
$50.3M Sell
762,879
-90,000
-11% -$5.94M 0.01% 746
2024
Q2
$78.8M Buy
852,879
+30,655
+4% +$2.83M 0.02% 548
2024
Q1
$78.6M Buy
822,224
+134,400
+20% +$12.8M 0.02% 551
2023
Q4
$52.4M Buy
687,824
+19,893
+3% +$1.52M 0.01% 664
2023
Q3
$46.3M Sell
667,931
-231,338
-26% -$16M 0.01% 678
2023
Q2
$84.8M Buy
899,269
+37,382
+4% +$3.53M 0.02% 493
2023
Q1
$71.3M Sell
861,887
-50,760
-6% -$4.2M 0.02% 538
2022
Q4
$68.1M Sell
912,647
-114,414
-11% -$8.54M 0.02% 538
2022
Q3
$84.9M Sell
1,027,061
-194,504
-16% -$16.1M 0.03% 432
2022
Q2
$116M Sell
1,221,565
-146,801
-11% -$14M 0.04% 365
2022
Q1
$161M Sell
1,368,366
-4,730
-0.3% -$557K 0.04% 332
2021
Q4
$178M Sell
1,373,096
-2,809,638
-67% -$364M 0.04% 309
2021
Q3
$474M Sell
4,182,734
-484,710
-10% -$54.9M 0.1% 182
2021
Q2
$483M Sell
4,667,444
-141,498
-3% -$14.7M 0.11% 181
2021
Q1
$402M Sell
4,808,942
-50,252
-1% -$4.2M 0.09% 206
2020
Q4
$443M Buy
4,859,194
+243,707
+5% +$22.2M 0.11% 186
2020
Q3
$368M Buy
4,615,487
+81,391
+2% +$6.5M 0.1% 190
2020
Q2
$313M Buy
4,534,096
+610,303
+16% +$42.2M 0.09% 213
2020
Q1
$247M Buy
3,923,793
+656,028
+20% +$41.2M 0.09% 222
2019
Q4
$254M Sell
3,267,765
-283,992
-8% -$22.1M 0.07% 278
2019
Q3
$260M Sell
3,551,757
-162,741
-4% -$11.9M 0.07% 258
2019
Q2
$229M Buy
3,714,498
+381,480
+11% +$23.5M 0.07% 295
2019
Q1
$213M Sell
3,333,018
-258,219
-7% -$16.5M 0.06% 306
2018
Q4
$183M Sell
3,591,237
-51,957
-1% -$2.65M 0.06% 308
2018
Q3
$211M Sell
3,643,194
-1,771,497
-33% -$103M 0.06% 314
2018
Q2
$263M Sell
5,414,691
-1,296,516
-19% -$62.9M 0.08% 262
2018
Q1
$312M Sell
6,711,207
-250,962
-4% -$11.7M 0.09% 218
2017
Q4
$262M Sell
6,962,169
-682,677
-9% -$25.6M 0.08% 273
2017
Q3
$279M Buy
7,644,846
+1,287,066
+20% +$46.9M 0.09% 236
2017
Q2
$251M Buy
6,357,780
+744,879
+13% +$29.4M 0.08% 256
2017
Q1
$176M Buy
5,612,901
+582,600
+12% +$18.3M 0.06% 336
2016
Q4
$157M Buy
5,030,301
+2,590,638
+106% +$80.9M 0.06% 362
2016
Q3
$98M Buy
2,439,663
+252,669
+12% +$10.2M 0.04% 513
2016
Q2
$72.7M Sell
2,186,994
-1,516,233
-41% -$50.4M 0.03% 588
2016
Q1
$109M Buy
3,703,227
+156,294
+4% +$4.6M 0.04% 441
2015
Q4
$93.4M Sell
3,546,933
-356,823
-9% -$9.39M 0.04% 487
2015
Q3
$92.5M Buy
3,903,756
+2,261,862
+138% +$53.6M 0.04% 488
2015
Q2
$39M Buy
1,641,894
+633,684
+63% +$15M 0.02% 944
2015
Q1
$23.9M Buy
1,008,210
+165,222
+20% +$3.92M 0.01% 1209
2014
Q4
$17.9M Buy
842,988
+241,224
+40% +$5.12M 0.01% 1361
2014
Q3
$10.2M Buy
601,764
+1,878
+0.3% +$32K ﹤0.01% 1757
2014
Q2
$8.58M Sell
599,886
-692,676
-54% -$9.91M ﹤0.01% 1914
2014
Q1
$16M Buy
1,292,562
+98,490
+8% +$1.22M 0.01% 1425
2013
Q4
$13.1M Sell
1,194,072
-704,232
-37% -$7.72M 0.01% 1533
2013
Q3
$22M Buy
1,898,304
+273,168
+17% +$3.17M 0.01% 1142
2013
Q2
$18.2M Buy
+1,625,136
New +$18.2M 0.01% 1197